Investors in Edtech

Linc invests in product oriented companies in the Nordic Life Science industry – primarily in pharmaceutical and medical technology companies. Their investments in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses.

Bonit Capital, a Swedish family-owned investment company, engages in diverse sectors and asset classes, including social investments and outcome models. In Venture Capital, Bonit focuses on life sciences, providing capital and industry expertise to ambitious founders in digital health, medical technology, and diagnostics.

The Nordic region is at the forefront of the technology and scientific revolution. Northislet's vision is to help create and build Nordic champions within Life Science, allowing them to grow and reach their potential in the hands of local entrepreneurs, employees, and shareholders. Their goal is to create long-term value for all stakeholders, fostering a prosperous environment for new and existing companies, entrepreneurs, and scientists, making the Nordic region a competitive and attractive place for global talent within Life Science. Northislet aims to become a leading Nordic investment company in Life Science over the next 25 years, with the journey just beginning.

NXT2B is a fully privately owned venture capital company capable of making fast investment decisions without requiring external capital. The NXT2B team has proven experience in commercializing innovative projects and partners with competent and ambitious entrepreneurs, focusing on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. They are prepared to invest in early-phase projects of high scientific quality and reasonable business potential, as well as in technology and consumer companies with unique ideas. Since its inception in 2011, NXT2B has invested in over 30 companies, offering active support to portfolio management teams to build market-leading companies.

BHV Partners is a venture builder specializing in creating healthcare startups by leveraging research and technology from academic and medical institutions. They collaborate closely with scientists to co-found ventures that address medical gaps, providing strategic guidance across technological, corporate, and funding aspects to enhance startup success and longevity. BHV Partners also offers consulting services to technology transfer offices and the biomedical industry. Recognized for their impact, they were named among the top 15 healthcare startups transforming patient care by EU Startup News in 2023.

Actyus was founded with the mission to invest in Fintech companies across Europe and Latin America, employing value creation strategies and active management. Benefiting from extensive expertise and exclusive access within the Fintech and private equity sectors, Actyus has a distinguished track record, having distributed over €1 billion in alternative products. Their portfolio includes notable companies such as Creditas, MyInvestor, BoomPay, LemonEnergia, Zippi, and Mundi.io, reflecting their commitment to supporting innovative ventures in the financial technology space.

Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.

Seaya raised its first funding in 2013 and currently manages over €650 million across five early-stage venture funds. Seaya accelerates the growth of startups by leveraging the founder’s strategic vision, providing them with Seaya’s global platform, its extensive network of founders, investors and multinational corporations, as well as all its experience in the global expansion of companies such as Glovo, Cabify, Wallbox (NYSE:WBX), Spotahome, Clarity AI, Clicars, Alma and RatedPower.

Unitatea Capital outlines its strategy to target differential businesses within specific verticals, aiming to enhance product value. Their focus lies particularly on early-stage ventures, valuing pre-seed and seed stages as pivotal for offering substantial support to entrepreneurial teams. With an average entry ticket of up to €50,000 per investment, they plan a comprehensive 4-year investment period to build a diverse portfolio. Their strategic vision revolves around investing in five fundamental pillars: Future of Work, Future of Mobility & Energy, Future of Education, Future of Food, and Future of Health, anticipating these sectors to drive significant societal transformation.

Demium is a talent investment company, founded in Valencia, Spain in 2013. Its goal is to endorse the best professionals and aid them to implement successful projects with a prominent digital and technological component. In June 2020, the Demium venture capital management launched a €50 million initial fund, investing annually in more than 75 startups in their pre-seed/seed phase, ergo becoming the most active Venture Capital fund in Spain. Demium's portfolio includes well-known startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu and Landbot, among others.

101 Ventures invests 0.5 m - 1m in seed stage tech and data driven companies across Europe with global ambition. They support tech and data driven business models, product-focused founders and sustainable business models.

Namarel Ventures is an early-stage investment firm focusing on the healthcare sector, specializing in supporting innovative, data-driven companies in medical devices, diagnostics, and digital health. They seek out committed entrepreneurs who share their vision of addressing unmet medical needs and advancing towards market success. Namarel Ventures prioritizes active involvement in projects where their expertise and experience can make a significant impact on the healthcare sector. While they do not have geographic constraints, their primary focus for investments is within Spain.